- $156.53m
- -$73.47m
- $17.20m
- 56
- 34
- 39
- 39
2019 December 31st | C2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 24.5 | 5.54 | 0.533 | 1.18 | 17.2 |
Cost of Revenue | |||||
Gross Profit | -12.2 | -9.47 | -7.15 | -12.1 | 1.17 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 50.8 | 35.1 | 60.2 | 104 | 99 |
Operating Profit | -26.4 | -29.6 | -59.6 | -103 | -81.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -28.7 | -40.2 | -59.2 | -98 | -66.2 |
Net Income After Taxes | -28.7 | -40.2 | -59.2 | -98 | -66.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -28.7 | -40.2 | -59.2 | -98 | -66.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -28.7 | -40.2 | -59.2 | -98 | -66.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.31 | -0.644 | -0.279 | -0.328 | -0.277 |